The "Delirium - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Delirium - Global Clinical Trials Review, 2024" provides an overview of ...
The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...
Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...
Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...
ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, ...
Medical Xpress on MSN3d
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemiaResearchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...
Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial ...
Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical ...
The "Cystic Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Cystic Fibrosis ...
The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback